XARELTO is a Kit in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is .
Product ID | 50458-584_271c2898-67e5-11e9-974e-d1c20099106d |
NDC | 50458-584 |
Product Type | Human Prescription Drug |
Proprietary Name | XARELTO |
Generic Name | Rivaroxaban |
Dosage Form | Kit |
Marketing Start Date | 2014-09-16 |
Marketing Category | NDA / NDA |
Application Number | NDA022406 |
Labeler Name | Janssen Pharmaceuticals, Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2014-09-16 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022406 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2016-11-01 |
Marketing Category | NDA |
Application Number | NDA022406 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-09-16 |
SPL SET ID: | 10db92f9-2300-4a80-836b-673e1ae91610 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50090-3625 | Xarelto | rivaroxaban |
50090-3639 | Xarelto | rivaroxaban |
50090-4468 | Xarelto | rivaroxaban |
50090-4469 | Xarelto | rivaroxaban |
50458-575 | Xarelto | rivaroxaban |
50458-577 | XARELTO | rivaroxaban |
50458-578 | Xarelto | rivaroxaban |
50458-579 | Xarelto | rivaroxaban |
50458-580 | Xarelto | Xarelto |
50458-584 | XARELTO | XARELTO |
55154-1423 | Xarelto | Xarelto |
55154-1424 | Xarelto | Xarelto |
55154-1422 | Xarelto | Xarelto |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XARELTO 78152154 2804753 Live/Registered |
Bayer Aktiengesellschaft 2002-08-08 |
XARELTO 77752463 4105934 Live/Registered |
Bayer Aktiengesellschaft 2009-06-04 |